直接植入与两阶段乳房再造:哪种技术更优?单机构104例患者分析
该回顾性研究纳入2015至2019年间在某大型跨州医疗系统内行乳房切除后植入物再造的104例患者,比较直接植入(DTI)与两阶段(TS)再造。DTI组并发症、再手术和医疗资源使用更高,但完成再造时间无差异。
要点
- DTI组复合并发症、再手术及医疗资源使用率高于TS组(81.0% vs 59.7%,P=0.03)。
- DTI组乳房切除皮瓣坏死率高于TS组(16.7% vs 1.6%,P<0.01)。
- 两组完成再造时间无显著差异(中位173天 vs 146天,P=0.25)。
核心结论
- 在该队列中,与TS再造相比,DTI再造与更高的并发症、再手术和医疗资源使用相关,但完成再造时间无差异。
- 需进一步研究探讨TS与DTI再造的患者报告结局和成本分析。
研究设计与样本
- 回顾性识别2015至2019年间在某大型跨州医疗系统内行乳房切除后植入物再造的患者,按再造技术分为TS组和DTI组。
- 共纳入104例患者,其中DTI组42例(40.4%),TS组62例(59.6%)。
- 采用风险调整的logistic回归和广义线性模型比较两组结局。
主要发现
- DTI组复合并发症、再手术和医疗资源使用率在单变量分析中高于TS组(81.0% vs 59.7%,P=0.03),风险调整分析中比值比为3.78(95%CI 1.09-13.9;P<0.04)。
- DTI组乳房切除皮瓣坏死率高于TS组(16.7% vs 1.6%,P<0.01)。
- DTI组因并发症再手术率高于TS组(33.3% vs 16.1%;P=0.04)。
- DTI组完成美学修整早于TS组(中位数256天 vs 479天,P<0.01;以DTI为参照,TS的预测平均差为298天,95%CI 71-525天;P<0.01)。
- 两组完成再造时间(首次至末次手术)无显著差异(中位数DTI vs TS为173天 vs 146天,P=0.25;以DTI为参照,预测平均差为-98天,95%CI -222至25.14天;P=0.11)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Two-stage (TS) implant-based reconstruction is the most commonly performed method of reconstruction after mastectomy. A growing number of surgeons are offering patients direct-to-implant (DTI) reconstruction, which has the potential to minimize the number of surgeries needed and time to complete reconstruction, as well as improve health care utilization. However, there are conflicting data regarding the outcomes and complications of DTI, and studies comparing the 2 methods exclusively are lacking. METHODS: Patients undergoing implant-based reconstruction after mastectomy within a large interstate health system between 2015 and 2019 were retrospectively identified and grouped by reconstruction technique (TS and DTI). The primary outcomes were a composite of complications (surgical site occurrences), health care utilization (reoperations, unplanned emergency department visits, and readmissions), and time to reconstruction completion. Risk-adjusted logistic and generalized linear models were used to compare outcomes between TS and DTI. RESULTS: Of 104 patients, 42 underwent DTI (40.4%) and 62 underwent TS (59.6%) reconstruction. Most demographic characteristics, and oncologic and surgical details were comparable between groups ( P > 0.05). However, patients undergoing TS reconstruction were more likely to be publicly insured, have a smoking history, and undergo skin-sparing instead of nipple-sparing mastectomy. The composite outcome of complications, reoperations, and health care utilization was higher for DTI reconstruction within univariate (81.0% vs 59.7%, P = 0.03) and risk-adjusted analyses (odds ratio, 3.78 [95% confidence interval [CI], 1.09-13.9]; P < 0.04). Individual outcome assessment showed increased mastectomy flap necrosis (16.7% vs 1.6%, P < 0.01) and reoperations due to a complication (33.3% vs 16.1%; P = 0.04) in the DTI cohort. Although DTI patients completed their aesthetic revisions sooner than TS patients (median, 256 days vs 479 [ P < 0.01]; predicted mean difference for TS [reference DTI], 298 days [95% CI, 71-525 days]; P < 0.01), the time to complete reconstruction (first to last surgery) did not differ between groups (median days, DTI vs TS, 173 vs 146 [ P = 0.25]; predicted mean difference [reference, DTI], -98 days [95% CI, -222 to 25.14 days]; P = 0.11). CONCLUSIONS: In this cohort of patients, DTI reconstruction was associated with higher complications, reoperations, and health care utilization with no difference in time to complete reconstruction compared with TS reconstruction. Further studies are warranted to investigate patient-reported outcomes and cost analysis between TS and DTI reconstruction.
引用
- Piper ML, Rios-Diaz AJ, Kimia R, et al. Direct-to-Implant Versus 2-Stage Breast Reconstruction: Which Technique Is Better? An Analysis of 104 Patients at a Single Institution. Ann Plast Surg. 2022. PMID: 35703187. doi:10.1097/SAP.0000000000003259
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。